Defendant B is 10% per annum from May 1, 2008 to the day of full payment with respect to the Plaintiff’s currency 200,100,000 UN and its related thereto.

Basic Facts

The Plaintiff is a company that engages in the manufacturing and selling business of the Jeon Seaball. Defendant A Co., Ltd. (hereinafter “Defendant Company”) is a Japanese company engaged in the research, development, manufacturing and selling business, etc. of stude (medical instruments for cardio-flue color treatment in order to prevent the lue and mathing, etc.). Defendant B is the former representative director of the Defendant Company.

On April 3, 2008, the Plaintiff entered into a share purchase contract with the Defendant Company and the Defendant Company to acquire 800 common shares (hereinafter “instant shares”) of 200,100,000 UN (hereinafter “instant share purchase contract”). On April 30, 2008, the Plaintiff paid 200,100,000 UN to the Defendant Company and acquired 800 common shares of the Defendant Company around that time.

The main contents of the instant sales contract are as follows.

(A) 1 and 2 evidence) . 5 - - an issuing company (referring to the defendant company) and/or an affiliate company of the issuing company (referring to the plaintiff) to conduct any of the following acts shall consult with the investor and obtain the written consent of the investor:

At this time, such written consent shall not be unreasonably withdrawn or delayed.

(1) Stockholm options or stock compensation, stock exchange, stock transfer, business transfer or acquisition, reduction of capital, change in the structure of capital, corporate division, etc. (2) decision on implementation of serious matters such as (3) establishment or change of subsidiaries or affiliates, but not limited to, but non-limited to, intellectual property, machinery or production facilities - Information disclosure obligation company continues to make investors in English the following information on affiliates of issuing companies and issuing companies: